https://www.selleckchem.com/pr....oducts/nocodazole.ht
These findings could address a significant bottleneck for future siRNA ligand conjugate development.Advances in immunostimulatory and anti-immunosuppressive therapeutics have revolutionized cancer treatment. However, novel immunotherapeutics with these dual functions are not frequently reported. Here we describe the creation of a heterodimeric bifunctional fusion molecule, HCW9218, constructed using our soluble tissue factor-based scaffold technology. This complex comprises extracellular domains of the human transforming growth facto
Like
Comment
Share
